Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hemangiosarcoma × avelumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Merkel Cell 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Penile Neoplasms 1 PD-L1 Positive Mutation Tumor 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Hodgkin Disease 1 Hemangiosarcoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Anus Neoplasms 1

Interventions

genexol-PM 1 brostallicin 1 avelumab 1 Urination 1 Temozolomide 1 Surveys and Questionnaires 1 Sorafenib 1 Propranolol 1 Paclitaxel 1 Molecular Diagnostic Techniques 1 Microarray Analysis 1 Interviews as Topic 1 Doxorubicin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03512834 2018-07-11

ASAP

Dong-A University Hospital

Phase 2 Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡